Literature DB >> 32580039

Tomatidine protects against ischemic neuronal injury by improving lysosomal function.

Anil Ahsan1, Yanrong Zheng1, Shijia Ma1, Mengru Liu1, Ming Cao1, Yue Li1, Wanqing Zheng1, Xinyu Zhou1, Minhang Xin1, Wei-Wei Hu1, Zhong Chen2, Xiangnan Zhang3.   

Abstract

Cerebral ischemia is a severe neurological disorder with limited therapy. Autophagy refers to the intracellular degradation process via an autophagosome-lysosome pathway. Emerging studies indicated the neuroprotective effects of autophagy against ischemic neuronal injury, suggesting the potential neuroprotection of autophagy-inducing compounds. Tomatidine is a gut microbiota-derived metabolite from unripe tomatoes. Tomatidine activates autophagy either in mammal cells or C elegans. However, potential neuroprotection of tomatidine against ischemic neuronal injury has not been determined. In the present investigation, N2a cells and primary cultured mice cortical neurons were subjected to oxygen-glucose deprivation followed by reperfusion (OGD/R). Cell injury was determined by MTT and lactate dehydrogenase release. Autophagosomes and autolysosomes were visualized by transfecting mCherry-GFP-tandem fluorescent LC3. The protein levels of LC3, Cathepsin D, Cathepsin B, and transcription factor EB (TFEB) were detected by Western blot. Lysosomes were stained with LysoTracker Red and dequenched-bovine serum albumin (DQ-BSA red). Tomatidine alleviated OGD/R-induced injury in N2a cells and neurons. Interestingly, tomatidine treatment attenuated, rather than reinforced, the OGD/R-elevated LC3-II, which can be reversed by lysosome inhibitor. These results indicated enhanced lysosomal activity rather than autophagosome generation with tomatidine treatment in our models. Indeed, tomatidine increased the lysosome number, proteolytic activities, as well as the expression of Cathepsin D and Cathepsin B. In addition, tomatidine increased the expression and nucleus translocation of (TFEB). Besides, lysosomal inhibitors chloroquine and bafilomycin, but not wortmannin, abolished the protection of tomatidine. In conclusion, the present study revealed the neuroprotection of tomatidine against ischemic injury by promoting lysosomal activity, possibly with the involvement of TFEB-related mechanisms.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autophagy flux; Cerebral ischemia; Lysosomal activation; Neuroprotection; TFEB; Tomatidine

Mesh:

Substances:

Year:  2020        PMID: 32580039     DOI: 10.1016/j.ejphar.2020.173280

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Targeting Adiponectin Receptor 1 Phosphorylation Against Ischemic Heart Failure.

Authors:  Di Zhu; Zhen Zhang; Jianli Zhao; Demin Liu; Lu Gan; Wayne Bond Lau; Dina Xie; Zhijun Meng; Peng Yao; Jumpei Tsukuda; Theodore A Christopher; Bernard L Lopez; Erhe Gao; Walter J Koch; Yajing Wang; Xin-Liang Ma
Journal:  Circ Res       Date:  2022-05-25       Impact factor: 23.213

2.  Tomatidine reduces Chikungunya virus progeny release by controlling viral protein expression.

Authors:  Berit Troost-Kind; Martijn J van Hemert; Denise van de Pol; Heidi van der Ende-Metselaar; Andres Merits; Malte Borggrewe; Izabela A Rodenhuis-Zybert; Jolanda M Smit
Journal:  PLoS Negl Trop Dis       Date:  2021-11-11

3.  Macrophage Subsets and Death Are Responsible for Atherosclerotic Plaque Formation.

Authors:  Hongxia Li; Zhiqiang Cao; Lili Wang; Chang Liu; Hongkun Lin; Yuhan Tang; Ping Yao
Journal:  Front Immunol       Date:  2022-03-30       Impact factor: 7.561

Review 4.  The Advances of Broad-Spectrum and Hot Anti-Coronavirus Drugs.

Authors:  Sen Zeng; Yuwan Li; Wenhui Zhu; Zipeng Luo; Keke Wu; Xiaowen Li; Yiqi Fang; Yuwei Qin; Wenxian Chen; Zhaoyao Li; Linke Zou; Xiaodi Liu; Lin Yi; Shuangqi Fan
Journal:  Microorganisms       Date:  2022-06-26

5.  Tomatidine provides mitophagy-independent neuroprotection after ischemic injury.

Authors:  Yu-Ting Wang; Li-Na Zhang; Xiao-Cui Lyu; Yue Li; Anil Ahsan; Zikai Feng; Xiangnan Zhang
Journal:  FEBS Open Bio       Date:  2021-08-23       Impact factor: 2.693

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.